Cerus (CERS) FCF Margin (QoQ) (2010 - 2026)
Cerus (CERS) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -980.00 |
| Dec 31, 2025 | 244.00 |
| Sep 30, 2025 | 53,562.00 |
| Jun 30, 2025 | -53,216.00 |
| Mar 31, 2025 | -771.00 |
| Dec 31, 2024 | -47,568.00 |
| Sep 30, 2024 | 47,998.00 |
| Jun 30, 2024 | -105.00 |
| Mar 31, 2024 | 1,043.00 |
| Dec 31, 2023 | 749,124.00 |
| Sep 30, 2023 | -747,513.00 |
| Jun 30, 2023 | 4,716.00 |
| Mar 31, 2023 | -6,986.00 |
| Dec 31, 2022 | 3,727.00 |
| Sep 30, 2022 | -3,783.00 |
| Jun 30, 2022 | 14,469.00 |
| Mar 31, 2022 | -14,424.00 |
| Dec 31, 2021 | 11,248.00 |
| Sep 30, 2021 | -5,459.00 |
| Jun 30, 2021 | 12,325.00 |